1. Oral 17β-estradiol/progesterone (TX-001HR) and quality of life in postmenopausal women with vasomotor symptoms. Issue 5 (May 2019) Authors: Simon, James A.; Kaunitz, Andrew M.; Kroll, Robin; Graham, Shelli; Bernick, Brian; Mirkin, Sebastian Journal: Menopause Issue: Volume 26:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Evaluation of clinical meaningfulness of estrogen plus progesterone oral capsule (TX-001HR) on moderate to severe vasomotor symptoms. Issue 5 (May 2019) Authors: Constantine, Ginger D.; Revicki, Dennis A.; Kagan, Risa; Simon, James A.; Graham, Shelli; Bernick, Brian; Mirkin, Sebastian Journal: Menopause Issue: Volume 26:Issue 5(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Relationship between vasomotor symptom improvements and quality of life and sleep outcomes in menopausal women treated with oral, combined 17β-estradiol/progesterone. Issue 6 (June 2019) Authors: Mirkin, Sebastian; Graham, Shelli; Revicki, Dennis A.; Bender, Randall H.; Bernick, Brian; Constantine, Ginger D. Journal: Menopause Issue: Volume 26:Issue 6(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Endometrial safety of low-dose vaginal estrogens in menopausal women: a systematic evidence review. Issue 7 (July 2019) Authors: Constantine, Ginger D.; Graham, Shelli; Lapane, Kate; Ohleth, Kathleen; Bernick, Brian; Liu, James; Mirkin, Sebastian Journal: Menopause Issue: Volume 26:Issue 7(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR)*. Issue 4 (April 2020) Authors: Mirkin, Sebastian; Goldstein, Steven R.; Archer, David F.; Pickar, James H.; Graham, Shelli; Bernick, Brian Journal: Menopause Issue: Volume 27:Issue 4(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Breast effects of oral, combined 17β-estradiol, and progesterone capsules in menopausal women: a randomized controlled trial. Issue 12 (December 2020) Authors: Liu, James H.; Black, Denise R.; Larkin, Lisa; Graham, Shelli; Bernick, Brian; Mirkin, Sebastian Journal: Menopause Issue: Volume 27:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. 17β-estradiol/progesterone in a single, oral, softgel capsule (TX-001HR) significantly increased the number of vasomotor symptom-free days in the REPLENISH trial. Issue 12 (December 2020) Authors: Kaunitz, Andrew M.; Bitner, Diana; Constantine, Ginger D.; Bernick, Brian; Graham, Shelli; Mirkin, Sebastian Journal: Menopause Issue: Volume 27:Issue 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. TX-001HR is associated with a clinically meaningful effect on severity of moderate to severe vasomotor symptoms in the REPLENISH trial. Issue 11 (November 2020) Authors: Constantine, Ginger D.; Simon, James A.; Kaunitz, Andrew M.; Pickar, James H.; Revicki, Dennis A.; Graham, Shelli; Bernick, Brian; Mirkin, Sebastian Journal: Menopause Issue: Volume 27:Issue 11(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Estradiol vaginal inserts (4 µg and 10 µg) for treating moderate to severe vulvar and vaginal atrophy: a review of phase 3 safety, efficacy and pharmacokinetic data. (2nd December 2018) Authors: Constantine, Ginger D.; Simon, James A.; Pickar, James H.; Archer, David F.; Bernick, Brian; Graham, Shelli; Mirkin, Sebastian Journal: Current medical research and opinion Issue: Volume 34:Number 12(2018) Page Start: 2131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effects of combined 17β-estradiol and progesterone on weight and blood pressure in postmenopausal women of the REPLENISH trial. Issue 1 (January 2021) Authors: Black, Denise R.; Minkin, Mary Jane; Graham, Shelli; Bernick, Brian; Mirkin, Sebastian Journal: Menopause Issue: Volume 28:Issue 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗